SCHEMBL19783019

SCHEMBL19783019

CCOC(=O)CCc1sc(NCc2ncccn2)nc1-c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 1/20 0.42
LMNA P02545 3/20 0.42
MAPK1 P28482 1/20 0.40
KDM6B O15054 1/20 0.40
KDM6A O15550 1/20 0.40
KDM4A O75164 1/20 0.40
KDM4B O94953 1/20 0.40
KDM5C P41229 1/20 0.40
KDM3B Q7LBC6 1/20 0.40
TET1 Q8NFU7 1/20 0.40
KDM2B Q8NHM5 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
KDM5B Q9UGL1 1/20 0.40
PHF8 Q9UPP1 1/20 0.40
KDM3A Q9Y4C1 1/20 0.40
APOBEC3G Q9HC16 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19783107 0.90 ALDH1A1 (0.47) ALDH1A1KDM4EHSD17B10HPGDHTT
SCHEMBL19782983 0.86 MAPT (0.45) ALDH1A1KDM4EHSD17B10HPGDHTT
SCHEMBL19783018 0.85 ADAMTS5 (0.50) ALDH1A1KDM4EHPGDAPOBEC3GMAPT
SCHEMBL19782726 0.81 LMNA (0.56) ALDH1A1KDM4EHSD17B10HPGDLMNA
SCHEMBL19782715 0.80 ADORA2A (0.40) ALDH1A1KDM4EHSD17B10HPGDHTT
SCHEMBL19783002 0.80 LMNA (0.36) ALDH1A1KDM4EHSD17B10HPGDHTT
SCHEMBL19783020 0.78 ADAMTS5 (0.36) ALDH1A1KDM4EHSD17B10HTTLMNA
SCHEMBL19782387 0.77 MAPT (0.36) ALDH1A1KDM4EHSD17B10HPGDHTT
SCHEMBL19783021 0.75 ALDH1A1 (0.49) ALDH1A1KDM4EHSD17B10HPGDHTT
SCHEMBL15993205 0.71 ALDH1A1 (0.41) ALDH1A1KDM4EHSD17B10HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913734-B2 Substituted aminothiazoles BARUCH S. BLUMBERG INSTITUTE 2021-02-09 US disclosed
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE 2019-08-08 US disclosed
WO-2018013508-A1 SUBSTITUTED AMINOTHIAZOLES BARUCH S. BLUMBERG INSTITUTE (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10913734-B2 Substituted aminothiazoles ABAT, AADAT, BCAT1 ALDH1A1 571/4885KDM4E 1505/4885HSD17B10 1584/4885
US-20190241552-A1 SUBSTITUTED AMINOTHIAZOLES ABAT, AADAT, BCAT1 ALDH1A1 571/4885KDM4E 1505/4885HSD17B10 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.